Paper39201561
AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of Glaucoma.
Millington-Ward S and 11 others. Int J Mol Sci, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of Glaucoma. Papers, record 39201561. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201561
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dependovirus | Major topic |
| Glaucoma | Major topic |
| Genetic Therapy | Major topic |
| Retinal Ganglion Cells | Major topic |
| Disease Models, Animal | Major topic |
| Oxidative Stress | Major topic |
| Genetic Vectors | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Mitochondria | |
| Mice, Inbred DBA | |
| Reactive Oxygen Species | |
| Swine |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 16/IA/4452 | Science Foundation Ireland | Ireland | PubMed | PubMed | |
| 22/FFP-A/10544 | Science Foundation Ireland | Ireland | PubMed | PubMed | |
| HRAPOR-2015-1140 | Health Research Board | Ireland | PubMed | PubMed | |
| StarT 813490 | EU Marie Curie Innovation Training Network | START813490 | PubMed | NIH RePORTER | |
| MRCG-2016-14 | Fighting Blindness Ireland - Health Research Charities Ireland | PubMed | PubMed |
References116
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33380270 | Mammalian Retinal Cell Quantification. | Toxicol Pathol | 2021 | https://conductscience.org/library/papers/33380270 | PubMed |
| 2 | 12367732 | Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR. | J Virol Methods | 2002 | https://conductscience.org/library/papers/12367732 | PubMed |
| 3 | 17251469 | Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia. | Invest Ophthalmol Vis Sci | 2007 | https://conductscience.org/library/papers/17251469 | PubMed |
| 4 | 17564969 | RNA interference-mediated suppression and replacement of human rhodopsin in vivo. | Am J Hum Genet | 2007 | https://conductscience.org/library/papers/17564969 | PubMed |
| 5 | 19005073 | Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand. | J Neurosci | 2008 | https://conductscience.org/library/papers/19005073 | PubMed |
| 6 | 32977483 | Diabetic Retinopathy: The Role of Mitochondria in the Neural Retina and Microvascular Disease. | Antioxidants (Basel) | 2020 | https://conductscience.org/library/papers/32977483 | PubMed |
| 7 | 23906962 | Elevated maxi-K(+) ion channel current in glaucomatous lamina cribrosa cells. | Exp Eye Res | 2013 | https://conductscience.org/library/papers/23906962 | PubMed |
| 8 | 25478814 | Cumulative mtDNA damage and mutations contribute to the progressive loss of RGCs in a rat model of glaucoma. | Neurobiol Dis | 2015 | https://conductscience.org/library/papers/25478814 | PubMed |
| 9 | 25278826 | Anterograde transport blockade precedes deficits in retrograde transport in the visual projection of the DBA/2J mouse model of glaucoma. | Front Neurosci | 2014 | https://conductscience.org/library/papers/25278826 | PubMed |
| 10 | 36835257 | RPE-Directed Gene Therapy Improves Mitochondrial Function in Murine Dry AMD Models. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36835257 | PubMed |
| 11 | 29392327 | Increased Substrate Stiffness Elicits a Myofibroblastic Phenotype in Human Lamina Cribrosa Cells. | Invest Ophthalmol Vis Sci | 2018 | https://conductscience.org/library/papers/29392327 | PubMed |
| 12 | 11328737 | Retinal morphology and ERG response in the DBA/2NNia mouse model of angle-closure glaucoma. | Invest Ophthalmol Vis Sci | 2001 | https://conductscience.org/library/papers/11328737 | PubMed |
| 13 | 18722368 | Oxidative injury to blood vessels and glia of the pre-laminar optic nerve head in human glaucoma. | Exp Eye Res | 2008 | https://conductscience.org/library/papers/18722368 | PubMed |
| 14 | 28973329 | The Ability of Nitric Oxide to Lower Intraocular Pressure Is Dependent on Guanylyl Cyclase. | Invest Ophthalmol Vis Sci | 2017 | https://conductscience.org/library/papers/28973329 | PubMed |
| 15 | 33998995 | Mitochondrial Dysfunction in Alzheimer's Disease: Opportunities for Drug Development. | Curr Neuropharmacol | 2022 | https://conductscience.org/library/papers/33998995 | PubMed |
| 16 | 37206187 | Mitochondrial dysfunction in glaucomatous degeneration. | Int J Ophthalmol | 2023 | https://conductscience.org/library/papers/37206187 | PubMed |
| 17 | 22653162 | Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. | Nat Protoc | 2012 | https://conductscience.org/library/papers/22653162 | PubMed |
| 18 | 35988157 | AAV-mediated gene therapy improving mitochondrial function provides benefit in age-related macular degeneration models. | Clin Transl Med | 2022 | https://conductscience.org/library/papers/35988157 | PubMed |
| 19 | 20950337 | Modulation of mitochondria in the axon and soma of retinal ganglion cells in a rat glaucoma model. | J Neurochem | 2010 | https://conductscience.org/library/papers/20950337 | PubMed |
| 20 | 30210817 | Contribution of autophagy to ocular hypertension and neurodegeneration in the DBA/2J spontaneous glaucoma mouse model. | Cell Death Discov | 2018 | https://conductscience.org/library/papers/30210817 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42395546 | A multi-organ spatial metabolomic atlas of exercising mice reveals neuronal Complex I as a convergent and sufficient axis for tau pathology reduction in PS19. | bioRxiv | 2026 | https://conductscience.org/library/papers/42395546 | PubMed |
| 42353231 | Gene Therapy Tools for Diseases Caused by Mutations of the Mitochondrial Genome. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353231 | PubMed |
| 41268594 | Research progress on molecular therapy for glaucoma (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/41268594 | PubMed |
| 40993346 | Validation of a Göttingen Minipig Gene Therapy Biodistribution Assay for AVGN7 Using Droplet Digital Polymerase Chain Reaction. | AAPS J | 2025 | https://conductscience.org/library/papers/40993346 | PubMed |
| 40298614 | Mitochondrial Dysfunction in Endothelial Cells: A Key Driver of Organ Disorders and Aging. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40298614 | PubMed |
| 40206485 | Challenging glaucoma with emerging therapies: an overview of advancements against the silent thief of sight. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40206485 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39201561
GET https://conductscience.org/api/papers/v1/39201561/references?page=2